The Jackson Laboratory, Bar Harbor, Maine
September 18-20, 2006
DRAFT SCHEDULE Subject to Change Discovery Strategies Conference 2006 “The Laboratory Mouse in the Development of New Therapeutic Approaches to the Treatment of Neurological Disease” September 18 – September 19, 2006 For more information, please contact Laura Lelansky, laura.lelansky@jax.org All events will be held The Bar Harbor Club unless otherwise specified Monday, September 18, 2006
7:00-8:00 a.m. Event Registration &Continental Breakfast 8:00-8:15 a.m Opening Remarks Rick Woychik, Ph.D. - The Jackson Laboratory Session I: Nociception Session Chair: John Macauley, Ph.D. – The Jackson Laboratory 8:15-9:10 a.m. Shad B. Smith – McGill University 9:10-10:05 a.m. Development of Novel Analgesics for Acute and Chronic Pain: Challenges and Opportunities Edward Bilsky, Ph.D. – University of New England 10:05-10:15 a.m. Session Chair – Q/A John Macauley, Ph.D – The Jackson Laboratory Overall Question for this session 10:15-10:30 a.m. Break Session II: Tools Applicable to Neuroscience Mouse Models Session Chair: Irene Nunes, Ph.D. – Merck & Co., Inc. 10:30-11:25 a.m. Raymond E. Gibson, Ph.D. - Merck & Co., Inc. 11:25-12:20 p.m. Douglas Wahlsten, Ph.D. – University of Alberta 12:20 – 1:15 p.m. Lunch Session III: Neuropsychiatric Disorders Session Chair: Jerry Jonak, Ph.D. - AstraZeneca 1:15 – 2:10 p.m. Gary E. Duncan, Ph.D. – The University of North Carolina, Chapel Hill 2:10 – 3:05 p.m. Akira Sawa, M.D., Ph.D. – Johns Hopkins University 3:05 – 4:00 p.m. Mark Von Zanstrow, M..D., Ph.D. - University of California, San Francisco 4:00 – 4:15 p.m. Break 4:15 – 5:10 p.m. Eduardo David Leonardo, M.D., Ph.D. – Columbia University 5:10 – 6:05 p.m. Guoping Feng, Ph.D. – Duke University 6:05-6:20 p.m. Session Chair – Q/A Jerry Jonak, Ph.D. – AstraZeneca 6:30-7:15 p.m. Social Hour and Poster Viewing 7:15-8:30 p.m. Banquet
Keynote Speaker 8:30-9:30 p.m. Wayne N. Frankel, Ph.D. – The Jackson Laboratory Tuesday, September 19, 2006
7:00-8:00 a.m. Continental Breakfast Session IV: Sleep Session Chair: Christine Dugovic, Ph.D. – Johnson & Johnson 8:00-8:55 a.m. Fred W. Turek, Ph.D.-Northwestern University 8:55-9:50 a.m. Brain Organization of Sleep James Krueger, Ph.D. – Washington State University 9:50-10:00 a.m. Break 10:00-10:55 a.m. Seiji Nishino, M.D., Ph.D. – Stanford University 10:55-11:50 a.m. Allan Pack, M.B, Ch.B., Ph.D. – University of Pennsylvania Session Chair – Q/A 11:50-12:00 a.m. Christine Dugovic, Ph.D. – Johnson & Johnson 12:00-12:45 p.m. Lunch Session V: Neurodegeneration, Models, and Mechanisms Session Chair: Robert Burgess, Ph.D. – The Jackson Laboratory 12:45 – 1:40 p.m. David R. Borchelt, Ph.D. - Evelyn F. & William L. McKnight Brain Institute of the University of Florida 1:40-2:35 p.m. Frank M. LaFerla, Ph.D. – University of California, Irvine 2:35-3:30 p.m. Sue Ackerman, Ph.D. – The Jackson Laboratory Session Chair – Q/A 3:30-3:45 p.m. Robert Burgess, Ph.D. – The Jackson Laboratory Meeting Adjourns 4:00 – 6:30 p.m. Exploring Acadia Park – Weather Permitting
|